ENZY - Enzymotec Ltd. - Ordinary Share

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
    Capital Cube9 months ago

    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018

    Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended September 30, 2017. Highlights Summary numbers: Revenues of USD 13.67 million, Net Earnings of USD 0.42 million. Gross margins widened from 66.03% to 69.53% compared to the same period last year, operating (EBITDA) margins now 7.02% from 1.27%. Change in operating cash ... Read more (Read more...)

  • Associated Press10 months ago

    Enzymotec posts 3Q profit

    The Migdal Haemeq, Israel-based company said it had net income of 2 cents per share. Earnings, adjusted for stock option expense and costs related to mergers and acquisitions, came to 7 cents per share. ...

  • Reuters11 months ago

    Israeli flavour firm Frutarom to buy remaining 81 pct of Enzymotec

    Israeli flavour and fine ingredients company Frutarom Industries said on Sunday it agreed to acquire the 81 percent of special nutrition firm Enzymotec it doesn't already own for $11.9 a share, or about $168 million. Frutarom had acquired in prior transactions 19 percent of Enzymotec for $42 million, reflecting an average share price of $9.6 and announced its intention to make a tender offer for Enzymotec shares. Enzymotec will become a wholly owned subsidiary of Frutarom and be delisted from trading.

  • Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
    Capital Cube11 months ago

    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 13.02 million, Net Earnings of USD -2.31 million. Gross margins narrowed from 69.99% to 50.24% compared to the same period last year, operating (EBITDA) margins now -14.43% from 6.99%. Change in operating cash ... Read more (Read more...)